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1. INTRODUCTION
Under Article 12(1) of Decision No 1786/2002/EC of the European Parliament and 
of the Council of 23 September 2002 adopting a programme of Community action in 
the field of public health (2003-2008)1, the Commission must regularly monitor the 
implementation of the actions under the programme in the light of the objectives. 
This report aims to inform the European Parliament and the Council of the 
implementation of the Public Health Programme in 2006. A report on the first three 
years of the Programme can be found on the Europa website2.
2. BUDGET OUTLINE
The programme’s overall budget for 2003-2008 was EUR 354 million. The budget 
for 2006 was estimated at EUR 55 817 661 in Commission Decision 2006/89/EC of 
10 February 2006 adopting the work plan for 2006 for the implementation of the 
programme of Community action in the field of public health (2003-2008), including 
the annual work programme for grants3. The operating budget and the administrative 
budget were estimated respectively at EUR 53 863 521 and EUR 1 954 140. The 
indicative amount for grants was EUR 47 798 344.
3. GRANTS
3.1. Call for proposals
A single call for proposals, covering all work plan activities for 2006, was published 
on 14 February 2006 and closed on 19 May 2006. It was published in the Official 
Journal4 and on the Europa website5. An information day was held on 22 February in 
Luxembourg for stakeholders and public health professionals interested in submitting 
proposals under the Public Health Programme. 
The indicative amount for the call for proposals was EUR 43 018 510.
A total of 281 applications were submitted for the three strands (121 for Health 
Information, 18 for Health Threats and 142 for Health Determinants). Thirty-three
  
1 OJ L 271, 09.10.2002, p. 1.
2 http://europa.eu.int/comm/health/ph_programme/keydo_programme_2003_2008_en.htm.
3 OJ L 42, 14.2.2006, p.29.
4 OJ C 37, 14.02.2006, p.14.
5 http://ec.europa.eu/health/ph_programme/howtoapply/proposal_docs/call2006_en.pdf.
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applications were excluded during the screening and selection phase, in most cases 
because the proposals were incomplete. The remaining 248 proposals were evaluated 
by the Public Health Executive Agency (PHEA) and reviewed by an Evaluation 
Committee composed of representatives of the Commission’s Directorates-General 
for Health and Consumer Protection and for Research, plus Eurostat and PHEA. The 
final list of proposals recommended for funding, the consolidated reserve list and 
proposals to be rejected were submitted to 28 external evaluators. As a result of the 
evaluation process, a list of 67 projects and a reserve list of 41 projects were drawn 
up.
More detailed information regarding the substance of the proposals, the number of 
proposals submitted by each Member State, the variation in success rates between 
applicants from different countries, and the impact of the information day, together 
with an analysis of the evaluation process, is available in “Call for Proposals 2006 —
Evaluation Summary”, published on the Public Health Executive Agency website6.
A Commission interservice consultation was held to ensure that projects selected for 
co-financing did not duplicate or overlap with ongoing projects in other DGs.
In September 2006, the Committee for the implementation of the Community action 
programme on public health (2003-2008) unanimously agreed to co-finance the 
proposals selected (totalling EUR 39 008 234 on the main list).
An increase in budget line 17 03 01 01 was requested by the Commission and 
approved by the Budget Authority in December 2006 with the specific purpose of 
financing a higher number of projects under the 2006 call for proposals for the Public 
Health Programme (2003-2008).
The above-mentioned Committee gave a favourable opinion on Commission 
Decision C(2007)3354 amending Decision C(2006)6429 on the awarding of grants 
for projects under the “Public health — 2006” programme7 (for an overall amount of 
EUR 47 399 457 for the 2006 call for proposals), which was adopted 
on 13 July 2007. All grant agreements under the 2006 call for proposals were then 
signed in 2007 for a total of 87 projects (namely, 32 projects on Health Information, 
12 projects on Health Threats and 43 projects on Health Determinants).
3.2. Calls for tender
A number of actions were initiated either by launching calls for tenders or by using 
the existing framework contracts. The most significant are listed below: 
– A Eurobarometer survey on health risks in the 25 Member States and 4 
neighbouring countries that covered perception of and information on the 
following four themes: potential health risks linked to electromagnetic fields, 
alcohol-related risks, smoking-related risks and organ donation. 
– Continuation of the maintenance and development of the Public Health Portal,
with the aim of improving its accessibility and of extending the number of 
languages available online.
  
6 http://ec.europa.eu/phea/documents/Evaluation_summary_REPORT_170107.pdf.
7 C(2007)3354 of 13.7.2007.
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– An administrative agreement with the Joint Research Centre (JRC) to provide
scientific support and advice on implementing Directive 2001/37/EC8 of the 
European Parliament and of the Council of 5 June 2001 on the approximation of 
the laws, regulations and administrative provisions of the Member States 
concerning the manufacture, presentation and sale of tobacco products. This 
support will help to harmonise the reporting system for tobacco ingredients, to 
enhance Member States’ tobacco control laboratory cooperation and to provide 
scientific advice on issues relevant to the regulatory process. 
– A report on the situation regarding drug treatment and sharing good practice, i.e. 
the quality of treatment services in Europe, with a specific focus on the 
development of know-how on drug treatment and sharing best practice. It also 
included the preparation of a Recommendation to develop “prevention, treatment 
and harm reduction services for people in prisons, reintegration services on 
release from prisons and methods to monitor/analyse drug use among prisoners”.
– A contract with Rand Europe to evaluate the uptake of healthy life years 
indicators.
3.3. Grants for international organisations
Cooperation with international organisations has been further developed. Seven 
direct grant agreements were signed with the World Health Organisation (WHO) and 
two with the Organisation for Economic Cooperation and Development (OECD).
Direct grants with the WHO, amounting to total co-funding of EUR 2 500 000, 
addressed the following issues:
– enhanced policy advice on the environment and health in Europe,
– implementation of existing recommendations on preventing injury and promoting
safety,
– equity in health — inequalities in health system performance and their social 
determinants in Europe,
– support for health security and preparedness planning in EU neighbouring 
countries,
– coordinated implementation of the framework for alcohol policy in Europe, 
– an assessment of emergency medical service preparedness in national crisis 
management structures in EU Member States.
Direct grant agreements with the OECD, amounting to total co-funding of 
EUR 800 000, addressed the following issues:
– work on health accounts,
  
8 JO L 194, 18.7.2001, p.26.
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– health workforce and international migration.
3.4. Sub-delegation to Eurostat
In accordance with Article 1.4.7 of the Work Plan for 20069, a budget of 
EUR 500 000 was set for sub-delegation to Eurostat. Under that Article, Eurostat 
launched two calls for proposal to support national statistical authorities:
– for the implementation in 2006-2008 of the European Core Health Interview 
Survey modules; 
– for the implementation and further expansion of the System of Health Accounts in 
the EU (in cooperation with OECD and the WHO). 
For the first, EUR 132 246.90 was ultimately sub-delegated and used for five grant 
agreements with Member States on the project “Implementation of the modules on 
health determinants, health care and background variables for the European Health 
Interview Survey (EHIS)”.
For the second, EUR 105 528.81 was ultimately sub-delegated and used for 
five grant agreements with Member States and for two with EFTA countries.
In other words, 47.56% of the total estimated sub-delegated budget was used for 10 
grant agreements with Member States and for two with EFTA countries.
4. STRUCTURAL SUPPORT
4.1. Executive Agency for the Public Health Programme
Technical, scientific and administrative assistance needed to implement the 2006 call 
for proposals was provided by the Executive Agency for the Public Health 
Programme (PHEA). The Agency, set up in 200510, became operational in 2006. It 
organised the 2006 call for proposals, coordinated the evaluation of the projects
submitted, and negotiated and signed the co-financing contracts.
5. PUBLIC HEALTH PROGRAMME 2003-2008: INTERIM EVALUATION 
The Public Health Programme Decision of 2002 provided for an external assessment 
of the first three years’ implementation and achievements of the programme, to be 
produced by the fourth year. The Inception Report was finalised in March 2006 and 
made available on the Europa site11. The Final (Interim Evaluation) Report was 
published in 2007 and is available on the Europa site12.
  
9 OJ L 42, 14.2.2006, p.29.
10 C(2004)4839 of 15.12.2004, OJ L 369, 16.12.2004, p. 73.
11 http://ec.europa.eu/health/ph_programme/documents/evaluation/inter_evaluation_en.pdf.
12 http://ec.europa.eu/health/ph_programme/documents/evaluation/PHP_evaluation_en.pdf.
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6. MAIN ACTIVITIES IN 2006
6.1. Health information
As part of the “health information and knowledge system” component of the EU 
Public Health Programme, a report on “Alcohol in Europe: A public health 
perspective”13 was published in June.
The First European Conference on Injury Prevention and Safety Promotion14 was 
held in Vienna in June. It was organised by the Austrian Presidency with the support 
of the European Commission. Also in June, a Commission Communication on 
“Actions for a Safer Europe”15 was adopted by the Commission.
Six Eurobarometer studies on different subjects (medical errors, AIDS prevention, 
food and health, tobacco attitudes, mental wellbeing, and health prevention) were 
implemented and published during the year in order to cover information gaps in 
these areas.
An e-Health High-Level Conference16 took place in May under the Austrian 
Presidency as part of the follow-up to the Commission Communication on E-Health. 
Another important project was launched in May: the Public Health Portal of the 
European Union17 providing a single point of access to health-related information at 
European, national and regional levels.
The “Europe for health and wealth” project18 was co-funded during the Finnish 
Presidency as part of the Presidency theme of Health in All Policies. The project 
aimed at influencing determinants of health in other national and Community 
policies and gathering the best available knowledge on good practices to engage 
other sectors in improving health and reducing health inequalities. As part of the 
project, the Presidency organised a high-level ministerial conference in September on 
the subject and produced a publication Health in All Policies: Prospects and 
potentials, in cooperation with the participating countries and the WHO European 
Observatory.
The PERISTAT project held a Congress “Better statistics for Better Health for 
pregnant women and their babies”,19 co-funded by the Public Health Programme, in Porto 
(Portugal) on 2-3 June. The congress included sessions on “Strategies for increasing 
the utilisation of perinatal health information”, “Perinatal health information systems 
& indicators”, “Analysing data from routine sources to evaluate practices and 
outcomes” and “Assessing geographic and social inequalities”. Over 110 health 
professionals, from 26 European countries plus Australia and the United States, 
attended the congress.
  
13 http://ec.europa.eu/health-eu/news_alcoholineurope_en.htm.
14 http://www.eurosafe.eu.com/csi/eurosafe.nsf/html/homepage/$file/index.htm.
15 http://ec.europa.eu/health/ph_determinants/environment/IPP/documents/com_328_en.pdf.
16 http://ec.europa.eu/health/ph_projects/2005/action1/action1_2005_3_en.htm.
17 http://health.europa.eu.
18 http://ec.europa.eu/health/ph_projects/2005/action1/action1_2005_full_en.htm#21.
19 http://ec.europa.eu/health/ph_information/documents/ev_20060602_prog_en.pdf.
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In June 2006, the Rare Diseases Task Force, funded by the Public Health Programme, submitted the 
report Contribution to policy shaping: For a European collaboration on health 
services and medical care in the field of rare diseases20 to the High-Level Group on 
Health Services and Medical Care, updating information on reference networks in 
Europe.
The European Primary Immunodeficiencies Consensus Conference21, co-funded 
by the Public Health Programme, took place in Frankfurt-am-Main on 19-20 June. 
More than 100 experts in clinical immunology, PID care, public health, and genetics, 
from EU/national ministries of health and agencies, academic centres, public health 
laboratories, industry, professional organisations and patient groups, were brought 
together to identify and develop public health strategies for PID.
6.2. Health threats
The beginning of the year was marked by four fatal human cases of avian influenza
in Turkey. This prompted a swift reaction by the Commission, the European Centre 
for Disease Prevention and Control (ECDC) and WHO, and all the response 
mechanisms set up in advance were activated, including sending a joint field team to 
assist the Turkish authorities. A new Web portal was set up to inform decision 
makers in Member States (HEDIS) and thereby played a pioneering role in EU-wide 
crisis preparations. The national preparedness of the Member States was assessed by 
teams of ECDC and Commission experts. A further joint WHO-Commission-ECDC 
conference on preparedness was held in Uppsala in May and the Health and 
Consumer Protection DG contributed to the success of the Beijing conference (where 
almost USD 2 billion was pledged for the global fight against avian flu and a 
pandemic), and to the follow-up conferences in Vienna and Bamako.
Measures to control a number of disease incidents notified by the EU’s Early 
Warning and Response System (EWRS), set up by Decision No 2119/98/EC22, were 
coordinated by the Health and Consumer Protection DG. The most important were 
the avian influenza cases in Turkey, the Chikungunya outbreak in the Indian Ocean 
area, several outbreaks of Norovirus infections in cruise ships, a case of Lassa fever 
imported from Africa to Europe and several cases of legionellosis diagnosed in EU 
citizens after a stay in a hotel in Thailand. In close collaboration with the ECDC, the 
Health and Consumer Protection DG prepared for a 2007 revision of the EU case 
definitions and the transfer of the operation of the EWRS system and related Public 
Health Programme projects on surveillance of communicable diseases to the ECDC.
Chemical and radionuclear threats. The Commission adopted a communication on 
prolonging the mandate of the Health Security Committee (HSC), which deals with 
deliberate releases of biological, chemical and radionuclear agents with the aim of 
causing harm. The Committee also coordinates influenza preparedness planning. The 
need to continue the work of this Committee was underlined by the further spread of 
avian influenza and the criminal use of polonium 210 in the United Kingdom, which 
  
20 http://ec.europa.eu/health/ph_threats/non_com/rare_8_en.htm.
21 http://www.eupidconference.com/Publications_Consensus.aspx.
22 Decision No 2119/98/EC of the European Parliament and of the Council of 24 September 1998 setting 
up a network for the epidemiological surveillance and control of communicable diseases in the 
Community, OJ L 268, 3.10.1998, p. 1–7.
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also led to contamination of several commercial aircraft, exposing a very high 
number of EU citizens to a potential radiological hazard. The ability to react to such 
events was further increased by the new web-based RAS-BICHAT system and the 
roll-out of the RAS-CHEM system, which are used for rapid notification of attacks 
and events involving biological, chemical and radionuclear agents.
Generic preparedness for health threats. In order to further improve the generic 
preparedness of the Commission and Member States, several steps were taken to 
implement the lessons learnt from two simulation exercises organised in 2005. 
Among other improvements, the Health and Consumer Protection DG set up an 
extended Crisis Team which makes available all suitable resources that the DG has 
for the management of a major crisis. The team’s work was supported by setting up 
new crisis rooms in Luxembourg and Brussels. The ability of Member States to use 
the available rapid alert and information systems was improved by special training 
sessions offered by the DG.
6.3. Health determinants
Following the “Communication on combating HIV/AIDS within the European
Union and in the neighbouring countries, 2006-2009”23, a high-level roundtable on 
safer sex for young people was set up. Its first achievement was the “AIDS 
remember me — Night of HIV/AIDS TV commercials” event in November. 
Cooperation and consultation with Member States and stakeholders continues, 
especially through the HIV/AIDS Think Tank and the HIV/AIDS Civil Society 
Forum.
Following a wide consultation process, the Commission adopted a “Communication 
on an EU strategy to support Member States in reducing alcohol related harm”24 in 
October. Five priority areas were identified that are relevant in all Member States 
and where Community action can add value to national policies: “Protect young 
people, children and the unborn child”; “Reduce injuries and death from alcohol-
related road accidents”; “Prevent alcohol-related harm among adults and reduce the 
negative impact on the workplace”; “Inform, educate and raise awareness on the 
impact of harmful and hazardous alcohol consumption, and on appropriate 
consumption patterns” and “Develop and maintain a common evidence base at EU 
level”. The Council Conclusions that were adopted in November 2006 welcomed the 
Commission Communication and endorsed the actions set out in it.
In September, the Commission published the results of the public consultation on the 
Green Paper “Promoting healthy diets and physical activity: a European dimension 
for the prevention of overweight, obesity and chronic diseases”25. The Commission 
continued stakeholder consultations and the impact assessment on a White Paper on 
Nutrition and Physical Activity26. The European Platform for Action on Diet, 
Physical Activity and Health tabled and started to implement 177 commitments on 
actions to halt and reverse current obesity trends. Exchanges on public-private 
  
23 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2005:0654:FIN:EN:PDF.
24 http://ec.europa.eu/health/ph_determinants/life_style/alcohol/documents/alcohol_com_625_en.pdf.
25 http://ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/nutrition_gp_en.pdf.
26 http://ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/nutrition_wp_en.pdf.
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partnerships between Platform members and similar actors in the United States were 
held in May.
The 2005-2008 “HELP: For a Life without Tobacco” EU anti-smoking campaign 
targeting mainly adolescents (15 to 18 year olds) and young adults (18 to 30 year 
olds) was continued. The campaign addressed the three main themes of tobacco
control (prevention, giving up, and the dangers of passive smoking) through a range 
of media including television and the Internet, the press and the organisation of 
public relations events. The CO measurement campaign launched in March racked 
up more than 90 000 tests and over 250 events were run EU-wide. Finally, the 
European Youth Manifesto against Tobacco27, drafted by young people themselves 
on the basis of 25 national consultations, was prepared for dissemination.
Extensive public consultation28 on the Green paper “Promoting the mental health of 
the population: Towards a strategy on mental health for the EU”29 of October 2005 
was held. The consultation confirmed strong support from the general public for the 
development of a mental health strategy at EU level.
The Commission cooperated with Member States and with international 
organisations, particularly with the WHO and its Commission on Social 
Determinants of Health, to promote understanding and policy development for action 
in the area of social determinants and health inequalities. The EU Expert Group 
on Social Determinants and Health Inequalities initiated a study of the 
macroeconomic implications of health inequalities and provided a mechanism for 
sharing good practice on national policy developments. Council conclusions on 
Health in All Policies were agreed under the Finnish presidency which stressed the 
importance of addressing social determinants of health through policies in a variety 
of sectors. The Commission’s discussion document for a new health strategy “Health 
in Europe: A Strategic Approach” proposed that one of the core threads of the new 
strategy should be action to help reduce health inequalities and narrow the health 
gaps within and between countries.
A report on the implementation of the Council Recommendation of 18 June 2003 on 
the prevention and reduction of health-related harm associated with drug 
dependence30 was drafted in 2006 and sent to the Council and Parliament in 2007. 
Preparations were started on a report on drugs treatment and a proposal for a 
Council Recommendation on drugs and prisons as set out in the European Drugs 
Action Plan due respectively in 2007 and in 2008.
A number of measures were taken under the EU Environment and Health Action 
Plan 2004-2010. An expert working group on indoor air quality was set up in 
October 2006 with a mandate to provide a forum for sharing best practice and 
information, to advise the Commission on EU programmes and polices related to 
indoor air quality, and to advise on actions aimed at reducing relevant pollutant 
emission/concentration.
  
27 http://ec.europa.eu/health/ph_determinants/life_style/Tobacco/help/manifesto_en.htm.
28 http://ec.europa.eu/health/ph_determinants/life_style/mental/green_paper/consultation_en.htm.
29 http://ec.europa.eu/health/ph_determinants/life_style/mental/green_paper/mental_gp_en.pdf.
30 http://eur-lex.europa.eu/LexUriServ/site/en/com/2007/com2007_0199en01.pdf.
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6.4. Risk assessment
The Scientific Committees relevant to the Public Health Programme (2003-2008) 
were financed as laid down in Article 1.4.6 of the Work Plan for 200631.
During 2006, the three Scientific Committees32, namely the Scientific Committee on 
Consumer Products (the SCCP), the Scientific Committee on Health and 
Environmental Risks (the SCHER), and the Scientific Committee on Emerging and 
Newly Identified Health Risks (the SCENIHR), adopted a wide range of opinions 
covering such matters as certain hair dyes (as part of a review of possible cancer 
risks), the safety of sun beds, existing substances under Regulation 793/93, other
substances like organotins, the possible effects of substances released by air 
freshener products, the effect of electromagnetic fields on human health and the 
appropriateness of existing methodologies for assessing the risks of nanomaterials.
To take account of new scientific data on electromagnetic fields, the Scientific 
Committee on Emerging and Newly Identified Health Risks33 (SCENIHR) was asked
to undertake a comprehensive review of the opinion of the Scientific Committee on 
Toxicity, Eco-toxicity and the Environment (SCTEE) of October 2001 on the 
possible health effects of electromagnetic fields, radio frequency fields and 
microwave radiation. The SCENIHR opinion was subject to public consultation from 
September to November and a final version was to be published in the first quarter of 
2007.
In the light of the results of a consultation launched in October 2005 on risk 
assessment methods for the products of nanotechnologies, in March the SCENIHR 
adopted an opinion on the appropriateness of existing methodologies to assess the 
potential risks of nanomaterials. The SCENIHR opinion concluded that some 
changes to current testing and monitoring methods would be needed to reflect the 
unique properties of nanotechnology products and highlighted the need for a case-by-
case approach to risk assessment. It also identified gaps in knowledge, especially 
regarding human exposure, health effects and the environmental impacts.
Cooperation between the Scientific Committees and panels of the Health and 
Consumer Protection Directorate-General, the Employment, Social Affairs and Equal 
Opportunities Directorate-General, the European Food Safety Authority, the 
European Centre for Disease Control, the European Medicines Agency and the 
European Environmental Agency was confirmed at their second meeting, as was 
their common interest in working together within a common framework for risk 
assessment.
  
31 OJ L 42, 14.2.2006, p. 29.
32 http://ec.europa.eu/health/ph_risk/committees/committees_en.htm.
33 http://ec.europa.eu/health/ph_risk/committees/04_scenihr/04_scenihr_en.htm.
